SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-003940
Filing Date
2024-03-26
Accepted
2024-03-26 16:02:10
Documents
17
Period of Report
2024-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20240326x8k.htm   iXBRL 8-K 29905
2 EX-99.1 ganx-20240326xex99d1.htm EX-99.1 173671
3 GRAPHIC ganx-20240326xex99d1001.jpg GRAPHIC 4388
4 GRAPHIC ganx-20240326xex99d1002.jpg GRAPHIC 4238
  Complete submission text file 0001558370-24-003940.txt   359259

Data Files

Seq Description Document Type Size
5 EX-101.SCH ganx-20240326.xsd EX-101.SCH 3923
6 EX-101.DEF ganx-20240326_def.xml EX-101.DEF 2826
7 EX-101.LAB ganx-20240326_lab.xml EX-101.LAB 17907
8 EX-101.PRE ganx-20240326_pre.xml EX-101.PRE 10618
20 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20240326x8k_htm.xml XML 5028
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 24783446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)